TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17619832

Group type: EXPERIMENTAL
Intervention: Quick Confusion Scale (QCS)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Mini-Mental Status Exam (MMSE)
Number of subjects: 666
Study: 16110205

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine (CHX) gel treatment
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (placebo gel or no gel treatment)
Number of subjects: 151
Study: 12171954

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily
Number of subjects: 3

Group type: COMPARATOR
Intervention: Misoprostol 200 micro g four times daily
Number of subjects: 3

Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 3
Study: 10522580

Group type: EXPERIMENTAL
Intervention: Plain 2-chloroprocaine 0.5%
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Alkalinized 2-chloroprocaine 0.5%
Number of subjects: 78

Group type: COMPARATOR
Intervention: Lidocaine 0.5%
Number of subjects: 78
Study: 7577205

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with bone marrow transplant
Number of subjects: 0
Study: 1823066

Group type: EXPERIMENTAL
Intervention: Cisapride, 10 mg t.i.d. for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ranitidine, 150 mg b.i.d. for 8 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cisapride and Ranitidine (comparison)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 120
Study: 6162015

Group type: EXPERIMENTAL
Intervention: Knowledge of plasma levels of anti-epileptic drugs (Group A)
Number of subjects: 127

Group type: COMPARATOR
Intervention: No knowledge of plasma levels of anti-epileptic drugs (Group B)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 127
Study: 30873060

Group type: EXPERIMENTAL
Intervention: Be a Mom intervention
Number of subjects: 194

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 194
Study: 26263223

Group type: EXPERIMENTAL
Intervention: Metformin (n = 28)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo (n = 27)
Number of subjects: 107
Study: 25468896

Group type: EXPERIMENTAL
Intervention: Lutein (10 mg/d) and Zeaxanthin (2 mg/d)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 21989119

Group type: EXPERIMENTAL
Intervention: Family-Based Group Behavioral Treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 40
Study: 19647607

Group type: EXPERIMENTAL
Intervention: Integrated Management of Childhood Illness (IMCI)
Number of subjects: 350000

Group type: COMPARATOR
Intervention: Usual services (comparison)
Number of subjects: 350000
Study: 17473202

Group type: EXPERIMENTAL
Intervention: Insulin treatment (0.11 +/- 0.05 units/kg/d) plus best available palliative support
Number of subjects: 138

Group type: COMPARATOR
Intervention: Best available palliative support
Number of subjects: 138
Study: 15185770

Group type: EXPERIMENTAL
Intervention: 0.6% amino acids/1.4% glycerol solution
Number of subjects: 10

Group type: COMPARATOR
Intervention: 2.27% glucose solution (control)
Number of subjects: 10
Study: 12195263

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9822092

Group type: EXPERIMENTAL
Intervention: bezafibrate (200 mg three times daily)
Number of subjects: 92

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 92
Study: 8121735

Group type: EXPERIMENTAL
Intervention: Individualized, family‐based intervention
Number of subjects: 34
Study: 2572566

Group type: EXPERIMENTAL
Intervention: Bevantolol 200 mg daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bevantolol 400 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1149359

Group type: EXPERIMENTAL
Intervention: Methoxamine (1.6 and 5.9 mug/kg/min)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Isoproterenol (0.015 and 0.026 mug/kg/min)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline (0.9% NaCl)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Propranolol (0.125 mg/kg)
Number of subjects: 5
Study: 31281606

Group type: EXPERIMENTAL
Intervention: Yoga exercises conducted by a yoga trainer and a psychiatrist or clinical psychologist expert in yoga
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 29092993

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 25840499

Group type: EXPERIMENTAL
Intervention: Emergency department and home intervention
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High SABA use
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid fills
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Positive cockroach sensitization
Number of subjects: 100
Study: 22739990

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA) plus Methotrexate (MTX) 15 mg/week
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo (PBO) plus Methotrexate (MTX) 15 mg/week
Number of subjects: 172
Study: 21190405

Group type: EXPERIMENTAL
Intervention: Web-based program as an adjunct to educator-delivered prevention intervention
Number of subjects: 0
Study: 18329197

Group type: EXPERIMENTAL
Intervention: Test formulation (cromolyn sodium nasal spray)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Reference formulation (cromolyn sodium nasal spray)
Number of subjects: 5
Study: 17262145

Group type: EXPERIMENTAL
Intervention: 1% sodium hypochlorite (NaOCl)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 2.5% sodium hypochlorite (NaOCl)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 5% sodium hypochlorite (NaOCl)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (no specific control mentioned)
Number of subjects: 111
Study: 12585948

Group type: EXPERIMENTAL
Intervention: Early intervention for children whose mothers had less than a high school education
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Overall cognitive improvement
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Children with early-onset IVH and significant CNS injury
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Increasing age, residence in a 2-parent household, higher levels of maternal education
Number of subjects: 296
Study: 10615848

Group type: EXPERIMENTAL
Intervention: Induced abortion
Number of subjects: 37247

Group type: COMPARATOR
Intervention: No induced abortion (control group)
Number of subjects: 37247

Group type: EXPERIMENTAL
Intervention: Induced abortion with age at first abortion <20 years
Number of subjects: 37247

Group type: EXPERIMENTAL
Intervention: Induced abortion after first birth
Number of subjects: 37247

Group type: EXPERIMENTAL
Intervention: Induced abortion with no prior births
Number of subjects: 37247

Group type: EXPERIMENTAL
Intervention: Induced abortion with early termination (0-2 months)
Number of subjects: 37247
Study: 9256573

Group type: EXPERIMENTAL
Intervention: 8-session Primary and Secondary Control Enhancement Training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 8390970

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate 1.0 g
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate 3.0 g
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (water only)
Number of subjects: 6
Study: 3089073

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (2-6 patches per day; mean 3.5)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin
Number of subjects: 20
Study: 31907002

Group type: EXPERIMENTAL
Intervention: Metta-based group meditation and individual cognitive behavioral therapy (MeCBT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Metta-based group meditation
Number of subjects: 48
Study: 31323599

Group type: EXPERIMENTAL
Intervention: Facebook discussion group intervention with motivational pictures, texts, and discussions
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Facebook discussion group intervention
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Baseline sufficient physical activity
Number of subjects: 375
Study: 27256016

Group type: COMPARATOR
Intervention: zoledronic acid (ZA)
Number of subjects: 707

Group type: COMPARATOR
Intervention: strontium-89 (Sr89)
Number of subjects: 707
Study: 26180346

Group type: EXPERIMENTAL
Intervention: Therapeutic recreation program for 3 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no therapeutic recreation program)
Number of subjects: 32
Study: 24755130

Group type: EXPERIMENTAL
Intervention: Morphine with flurbiprofen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Morphine alone
Number of subjects: 60
Study: 22890503

Group type: EXPERIMENTAL
Intervention: Xylitol gum (mean 3.8 g/day, 2.9 times/day) for 13 months
Number of subjects: 107

Group type: COMPARATOR
Intervention: No gum (control group)
Number of subjects: 107
Study: 19162389

Group type: EXPERIMENTAL
Intervention: Overt speech task with tongue movement, lip movement, and vowel phonation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voxel‐based meta‐analysis of syllable‐singing (11 studies)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previously‐published meta‐analysis of oral reading (11 studies)
Number of subjects: 0
Study: 17227801

Group type: EXPERIMENTAL
Intervention: Annual iv administration of 4 mg zoledronate
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 15189592

Group type: EXPERIMENTAL
Intervention: Cognitive load participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No load participants (initial ratings)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No load participants (later ratings)
Number of subjects: 0
Study: 10989241

Group type: EXPERIMENTAL
Intervention: Transdermal ethinyl estradiol (EE) in Group A (n=14)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No therapy in Group B (n=12)
Number of subjects: 41
Study: 8846126

Group type: EXPERIMENTAL
Intervention: High dose 6-mercaptopurine (HD‐6MP) 1300 mg/m(2).24h
Number of subjects: 9

Group type: COMPARATOR
Intervention: High dose 6-mercaptopurine (HD‐6MP) 1300 mg/m(2).24h with allopurinol (200 mg/m(2).day)
Number of subjects: 9
Study: 1480728

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg once daily, titrated up to 200 mg if necessary)
Number of subjects: 100
Study: 6489485

Group type: EXPERIMENTAL
Intervention: Supine position for 4 hours
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Supine position for 0.5 h, 2 h, and 4 h
Number of subjects: 10

Group type: COMPARATOR
Intervention: Upright position (control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Return to upright position after supine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 10
Study: 3959273

Group type: EXPERIMENTAL
Intervention: Combined operation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Coronary artery surgery performed first (staged procedure)
Number of subjects: 70
Study: 30283911

Group type: EXPERIMENTAL
Intervention: Folic acid (1 mg daily)
Number of subjects: 1021

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1021

Group type: EXPERIMENTAL
Intervention: Folic acid and/or vitamin B12 (in meta-analysis)
Number of subjects: 1021

Group type: COMPARATOR
Intervention: Control (placebo in meta-analysis)
Number of subjects: 1021
Study: 27523051

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Ondansetron (4 mg)
Number of subjects: 85
Study: 24721352

Group type: EXPERIMENTAL
Intervention: Penehyclidine inhalation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide inhalation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline inhalation
Number of subjects: 90
Study: 24573620

Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine
Number of subjects: 205

Group type: COMPARATOR
Intervention: 0.5% chlorhexidine-alcohol
Number of subjects: 205
Study: 19836144

Group type: EXPERIMENTAL
Intervention: Bupropion SR (300 mg/day for 6 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 19046091

Group type: EXPERIMENTAL
Intervention: Complete supine PCNL
Number of subjects: 80

Group type: COMPARATOR
Intervention: Prone PCNL
Number of subjects: 80
Study: 16604131

Group type: EXPERIMENTAL
Intervention: Desmopressin (30 microg intranasal administration) under no hydration (NH-Des)
Number of subjects: 6

Group type: COMPARATOR
Intervention: False hydration (FH-Des)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No hydration (NH)
Number of subjects: 6

Group type: COMPARATOR
Intervention: False hydration (FH)
Number of subjects: 6
Study: 12702129

Group type: EXPERIMENTAL
Intervention: SQV/RTV 1000 mg/100 mg twice daily (BID) as hard gelatin capsule (HGC) for 10 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: SQV/RTV 1000 mg/100 mg twice daily (BID) as soft gelatin capsule (SGC) for 10 days
Number of subjects: 24
Study: 10990524

Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease
Number of subjects: 121

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 121
Study: 9424322

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) concentrations of TNF-alpha and CRP in patients with bacterial meningitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) concentrations of TNF-alpha and CRP in differential diagnosis of meningitis
Number of subjects: 0
Study: 1402495

Group type: COMPARATOR
Intervention: Skin shaving (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: No skin shaving (experiment group)
Number of subjects: 80
Study: 3907277

Group type: EXPERIMENTAL
Intervention: Imipramine + Dixyrazine (50 mg/day)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Imipramine + Placebo
Number of subjects: 63

Group type: COMPARATOR
Intervention: Imipramine + Diazepam (10 mg/day)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Imipramine + Dixyrazine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Imipramine + Diazepam
Number of subjects: 63
Study: 29621908

Group type: EXPERIMENTAL
Intervention: Telemonitoring (TM)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 82
Study: 28762106

Group type: EXPERIMENTAL
Intervention: Sertraline (part of a multicentre randomised placebo-controlled trial)
Number of subjects: 707

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 707
Study: 25780258

Group type: EXPERIMENTAL
Intervention: Neck and shoulder stretching exercises two times/day, five days/week for four weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Informative brochure on proper position and ergonomics
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Exercising ≥3 times/week
Number of subjects: 96
Study: 24445573

Group type: EXPERIMENTAL
Intervention: Psychosocial assessments including anxiety and depression
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Medical outcomes study short-form-36 (SF-36) physical and mental composite scores
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Pain burden assessment
Number of subjects: 214

Group type: COMPARATOR
Intervention: Comparison of psychosocial parameters
Number of subjects: 214
Study: 22283559

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg once daily for 12 days followed by DMQ 30 mg/30 mg twice daily for 8 days (Group 1)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: DMQ 30 mg/30 mg twice daily for 8 days followed by paroxetine 20 mg once daily for 12 days (Group 2)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Paroxetine monotherapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: DMQ alone
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination therapy (DMQ + paroxetine)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Paroxetine alone
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination therapy (paroxetine + DMQ)
Number of subjects: 27
Study: 20024591

Group type: EXPERIMENTAL
Intervention: Treatment with hop rho iso-alpha acids (200 mg), berberine sulfate trihydrate (100 mg), vitamin D3 (500 IU), and vitamin K1 (500 mcg), twice daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Treatment with hop rho iso-alpha acids, berberine sulfate trihydrate, vitamin D3 and vitamin K1
Number of subjects: 32
Study: 18672608

Group type: EXPERIMENTAL
Intervention: 25-gauge Pajunk(AE) spinal needle
Number of subjects: 91

Group type: COMPARATOR
Intervention: 27-gauge Quincke spinal needle
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Both groups (Pajunk(AE) and Quincke)
Number of subjects: 91
Study: 16448251

Group type: EXPERIMENTAL
Intervention: Teeth washed and immersed in iodine solution (experimental group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Teeth washed with distilled water (control group)
Number of subjects: 40
Study: 12663359

Group type: EXPERIMENTAL
Intervention: Cycling at 60 rpm
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cycling at 80 rpm
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cycling at 100 rpm
Number of subjects: 9

Group type: COMPARATOR
Intervention: Isolated run (no cycling)
Number of subjects: 9
Study: 14564591

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 13

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 13
Study: 8675502

Group type: EXPERIMENTAL
Intervention: Acellular allograft dermal matrix with split-thickness autograft
Number of subjects: 67

Group type: COMPARATOR
Intervention: Split-thickness autograft alone (Control)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Thin split-thickness autografts plus allograft dermal matrix
Number of subjects: 67
Study: 1705140

Group type: EXPERIMENTAL
Intervention: F2 regimen (17 Gy in two fractions of 8.5 Gy 1 week apart)
Number of subjects: 369

Group type: COMPARATOR
Intervention: FM regimen (30 Gy in ten fractions or 27 Gy in six fractions)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Both F2 and FM regimens
Number of subjects: 369
Study: 6824149

Group type: EXPERIMENTAL
Intervention: Etomidate 100 micrograms/kg/minute with fentanyl 1 microgram/kg/minute for 10 minutes, followed by a maintenance dose at a rate of one-tenth this amount
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Atropine intravenously prior to induction
Number of subjects: 90
Study: 31498138

Group type: EXPERIMENTAL
Intervention: Nintendo Wii (NW) plus Conventional Exercises (CE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nintendo Wii (NW) alone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional Exercises (CE) alone
Number of subjects: 45
Study: 28743190

Group type: EXPERIMENTAL
Intervention: CPAP plus usual care
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 200
Study: 25936324

Group type: EXPERIMENTAL
Intervention: Lipoprotein apheresis (LA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (Cohort II)
Number of subjects: 50
Study: 24434529

Group type: EXPERIMENTAL
Intervention: Ecopipam 50 mg daily (weeks 1-2) and then 100 mg daily (weeks 3-8)
Number of subjects: 18
Study: 21946197

Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 146

Group type: COMPARATOR
Intervention: Heparin-free
Number of subjects: 146
Study: 19135805

Group type: EXPERIMENTAL
Intervention: Greater amplitude of diurnal cortisol secretion
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lower amplitude of diurnal cortisol secretion
Number of subjects: 18
Study: 17471090

Group type: EXPERIMENTAL
Intervention: Intraoperative esophagus retraction during anterior cervical surgery
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group of 32 lumbar surgery patients
Number of subjects: 92
Study: 15286134

Group type: EXPERIMENTAL
Intervention: Various methods for analysis of multiple outcomes (rank sum, ordinary least squares, general least squares, generalized estimating equations)
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Two caries indices (based on average and maximum values of the methods)
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: New hybrid method
Number of subjects: 1063
Study: 11918249

Group type: EXPERIMENTAL
Intervention: Vibration stimulation
Number of subjects: 95

Group type: COMPARATOR
Intervention: Erotic videotape
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Combination of vibration and erotic videotape
Number of subjects: 95
Study: 9084953

Group type: EXPERIMENTAL
Intervention: Faces Pain Scale
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Poker Chip Tool
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Visual Analogue Toy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Verbal Rating Scale
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Behavioral checklist
Number of subjects: 50
Study: 7959330

Group type: EXPERIMENTAL
Intervention: hCG
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control (no hCG)
Number of subjects: 149
Study: 3605735

Group type: EXPERIMENTAL
Intervention: MTC 0.03 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline 0.015 ml/kg
Number of subjects: 12
Study: 28255736

Group type: EXPERIMENTAL
Intervention: 3D/HD robotic scope
Number of subjects: 98

Group type: COMPARATOR
Intervention: 2D/HD laparoscope
Number of subjects: 98
Study: 28340322

Group type: EXPERIMENTAL
Intervention: DTPa‐HBV‐IPV/Hib formulation A (DATAPa‐HBV‐IPV/Hib)
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: DTPa‐HBV‐IPV/Hib formulation B (DBTBPa‐HBV‐IPV/Hib)
Number of subjects: 721

Group type: COMPARATOR
Intervention: Licensed DTPa‐HBV‐IPV/Hib vaccine (Infanrix hexa, GSK)
Number of subjects: 721
Study: 25645987

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg three times per week
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg on-demand
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 129